• Users Online: 30
  • Print this page
  • Email this page
This article has been cited by
1Recent Advances in Clinical Diagnosis and Pharmacotherapy Options of Membranous Nephropathy
Yan-Ni Wang,Hao-Yu Feng,Xin Nie,Ya-Mei Zhang,Liang Zou,Xia Li,Xiao-Yong Yu,Ying-Yong Zhao
Frontiers in Pharmacology.2022;13()
[DOI]
2Intrarenal 1-methoxypyrene, an aryl hydrocarbon receptor agonist, mediates progressive tubulointerstitial fibrosis in mice
Gang Cao,Hua Miao,Yan-ni Wang,Dan-qian Chen,Xia-qing Wu,Lin Chen,Yan Guo,Liang Zou,Nosratola D. Vaziri,Ping Li,Ying-yong Zhao
Acta Pharmacologica Sinica.2022;43(11)2929
[DOI]
3Recent advances of gut microbiota in chronic kidney disease patients
Ying-Yong Zhao
Exploration of Medicine.2022;43(11)260
[DOI]
4Membranous nephropathy: Systems biology-based novel mechanism and traditional Chinese medicine therapy
Hua Miao,Yamei Zhang,Xiaoyong Yu,Liang Zou,Yingyong Zhao
Frontiers in Pharmacology.2022;13(11)260
[DOI]